• Chief Patient Officer and Principal Vice President of Patient Voice Strategy & Alliances.

• Not considered independent under the Danish Corporate Governance Recommendations.
• Employed in Novo Nordisk since 1992.
• Employee-elected member of the Board of Directors since March 2022 for a term of four years (term expires in March 2026). Previously employee-elected member of the Board of Directors from 2014-2018.
• Member of the Research & Development Committee since March 2022.

• 2018: Board Leadership Programme, Copenhagen Business School, Denmark.
  
• 2014: Board Leadership Masterclass, Copenhagen Business School, Denmark.
• 2011: Master of Medical Business Strategy, Copenhagen Business School, Denmark.
  
• 1992: MSc, Pharmacy, University of Copenhagen, Denmark.
  

Danish, born 1966. Female.